Your browser doesn't support javascript.
loading
The ε4 genotype of apolipoprotein E and white matter integrity in Alzheimer's disease.
Kljajevic, Vanja; Meyer, Peter; Holzmann, Carsten; Dyrba, Martin; Kasper, Elisabeth; Bokde, Arun L W; Fellgiebel, Andreas; Meindl, Thomas; Hampel, Harald; Teipel, Stefan.
Afiliación
  • Kljajevic V; DZNE, German Center for Neurodegenerative Diseases, Rostock, Germany. Electronic address: vanja.kljajevic@gmail.com.
  • Meyer P; Institute of Medical Genetics, University Medicine, Rostock, Germany.
  • Holzmann C; Institute of Medical Genetics, University Medicine, Rostock, Germany.
  • Dyrba M; DZNE, German Center for Neurodegenerative Diseases, Rostock, Germany; Mobile Multimedia Information Systems Group, University of Rostock, Rostock, Germany.
  • Kasper E; DZNE, German Center for Neurodegenerative Diseases, Rostock, Germany.
  • Bokde AL; Cognitive Systems Group, Discipline of Psychiatry, School of Medicine, Trinity College Dublin, Dublin, Ireland; Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.
  • Fellgiebel A; Department of Psychiatry, University Medical Center of Mainz, Mainz, Germany.
  • Meindl T; Department of Magnetic Resonance Imaging, Institute for Clinical Radiology, Ludwig Maximilian University Munich, Munich, Germany.
  • Hampel H; Department of Psychiatry, University of Frankfurt, Frankfurt, Germany.
  • Teipel S; DZNE, German Center for Neurodegenerative Diseases, Rostock, Germany; Department of Psychiatry, University of Rostock, Rostock, Germany.
Alzheimers Dement ; 10(3): 401-4, 2014 May.
Article en En | MEDLINE | ID: mdl-23706516
ABSTRACT

BACKGROUND:

In this multicenter study, we investigated a possible association between the APOE ε4 allele and white matter (WM) integrity in Alzheimer's disease (AD) using diffusion tensor imaging (DTI).

METHODS:

We analyzed fractional anisotropy (FA) and mean diffusivity (MD) as indices of WM integrity in 70 AD patients (35 APOE ε4 carriers, 35 noncarriers) and 56 healthy control (HC) subjects (28 APOE ε4 carriers, 28 noncarriers). APOE ε4 carriers and noncarriers were matched for age and gender within each diagnostic group.

RESULTS:

We found significant effects of diagnosis (Pcorrected < .05 [FWE]; i.e., smaller FA values and larger MD values in AD patients compared with HCs) and significant effects (P < .001) of APOE ε4 carrier status on MD in HCs but not in AD subjects.

CONCLUSIONS:

The results indicate that APOE ε4 has a moderate effect on WM integrity in HCs, but no effect on WM integrity in manifest AD.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Encéfalo / Apolipoproteína E4 / Enfermedad de Alzheimer / Sustancia Blanca Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Alzheimers Dement Año: 2014 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Encéfalo / Apolipoproteína E4 / Enfermedad de Alzheimer / Sustancia Blanca Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Alzheimers Dement Año: 2014 Tipo del documento: Article